Mark Tuthill

1.1k total citations
19 papers, 332 citations indexed

About

Mark Tuthill is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Mark Tuthill has authored 19 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Genetics. Recurrent topics in Mark Tuthill's work include Cancer Immunotherapy and Biomarkers (5 papers), Renal cell carcinoma treatment (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Mark Tuthill is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Renal cell carcinoma treatment (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Mark Tuthill collaborates with scholars based in United Kingdom, Greece and Netherlands. Mark Tuthill's co-authors include Eleftheria Hatzimichael, Andrew Protheroe, Eliana MC Tacconi, Tim Crook, Jenny King, Andrew Webb, Eve Fryer, Anna Olsson‐Brown, Sreedhar Subramanian and Paul Klenerman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mark Tuthill

16 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Tuthill United Kingdom 9 142 75 61 59 59 19 332
Zimu Gong United States 11 243 1.7× 78 1.0× 45 0.7× 42 0.7× 62 1.1× 35 399
Elisa Carraro Italy 12 104 0.7× 108 1.4× 60 1.0× 88 1.5× 47 0.8× 37 392
PM Parikh India 10 117 0.8× 113 1.5× 120 2.0× 70 1.2× 58 1.0× 42 334
Stefano Fiori Italy 9 91 0.6× 40 0.5× 19 0.3× 55 0.9× 50 0.8× 30 258
Tomoko Yanai Japan 10 174 1.2× 52 0.7× 42 0.7× 109 1.8× 25 0.4× 29 399
Rina Kansal United States 13 98 0.7× 65 0.9× 32 0.5× 63 1.1× 74 1.3× 27 359
Francesca Lunghi Italy 8 164 1.2× 109 1.5× 42 0.7× 66 1.1× 51 0.9× 19 378
Chunju Zhou China 10 99 0.7× 25 0.3× 80 1.3× 93 1.6× 31 0.5× 49 326
Elizabeth L. Courville United States 11 147 1.0× 136 1.8× 25 0.4× 36 0.6× 82 1.4× 46 376
Robert Peter Gale United States 7 168 1.2× 125 1.7× 69 1.1× 48 0.8× 69 1.2× 12 395

Countries citing papers authored by Mark Tuthill

Since Specialization
Citations

This map shows the geographic impact of Mark Tuthill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tuthill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tuthill more than expected).

Fields of papers citing papers by Mark Tuthill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Tuthill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tuthill. The network helps show where Mark Tuthill may publish in the future.

Co-authorship network of co-authors of Mark Tuthill

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Tuthill. A scholar is included among the top collaborators of Mark Tuthill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Tuthill. Mark Tuthill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Aurer, Igor, Paul Moss, Michel Goldman, et al.. (2025). COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review. The Oncologist. 30(6).
2.
Agarwal, Neeraj, James Brugarolas, Pooja Ghatalia, et al.. (2024). Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma. Annals of Oncology. 35(12). 1148–1156. 6 indexed citations
3.
Brugarolas, James, Pooja Ghatalia, S. George, et al.. (2023). 1881O Safety and efficacy of two doses of belzutifan in patients (pts) with advanced RCC: Results of the randomized phase II LITESPARK-013 study. Annals of Oncology. 34. S1011–S1011. 4 indexed citations
4.
Challapalli, Amarnath, John McGrane, Sarah Kingdon, et al.. (2022). 1463P Patterns of care and outcomes of metastatic renal cell carcinoma (mRCC) patients (pts) with bone metastases (BM): A UK multicenter review. Annals of Oncology. 33. S1215–S1215.
5.
Hill, Adrian V. S., Mark Tuthill, Federica Cappuccini, et al.. (2021). Abstract IA11: Viral vectored vaccines for prostate cancer. Cancer Immunology Research. 9(2_Supplement). IA11–IA11.
6.
7.
Tacconi, Eliana MC, Mark Tuthill, & Andrew Protheroe. (2020). <p>Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to Date</p>. OncoTargets and Therapy. Volume 13. 12301–12316. 24 indexed citations
8.
Cheung, Vincent, Tarun Gupta, Anna Olsson‐Brown, et al.. (2020). Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?. British Journal of Cancer. 123(2). 207–215. 57 indexed citations
9.
Macpherson, Iain R., Lucy Kilburn, Sarah Kernaghan, et al.. (2020). Abstract P1-19-04: Results from plasmaMATCH trial treatment cohort A: A phase II trial of extended-dose fulvestrant in patients with an ESR1 mutation identified via ctDNA screening (CRUK/15/010). Cancer Research. 80(4_Supplement). P1–19. 1 indexed citations
10.
11.
Protheroe, Andrew, Robert Watson, Clare Verrill, et al.. (2018). Non-germ cell testicular tumours: Follow-up and outcomes—A literature review and experience from a UK tertiary referral centre over 13 years.. Journal of Clinical Oncology. 36(15_suppl). e16536–e16536. 1 indexed citations
12.
13.
Peña, Hugo De La, Anand Sharma, Caroline Glicksman, et al.. (2017). No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer. European Journal of Cancer. 84. 354–359. 16 indexed citations
14.
Tuthill, Mark & Eleftheria Hatzimichael. (2010). Hematopoietic stem cell transplantation. PubMed. 3. 105–105. 96 indexed citations
15.
Tuthill, Mark, Frederick Chen, Samantha Paston, et al.. (2009). The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation. Cancer Immunology Immunotherapy. 58(9). 1481–1488. 14 indexed citations
16.
Tuthill, Mark, Ravi Barod, L Pyle, et al.. (2009). A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinib. BMJ Case Reports. 2009. bcr0820080732–bcr0820080732. 12 indexed citations
17.
Tuthill, Mark, et al.. (2009). Rapid infusion of rituximab over 60 min. European Journal Of Haematology. 82(4). 322–325. 34 indexed citations
18.
Bower, Mark, Justin Stebbing, Mark Tuthill, et al.. (2008). Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma. Blood. 111(8). 3986–3990. 22 indexed citations
19.
Hatzimichael, Eleftheria & Mark Tuthill. (2000). Hematopoietic Stem Cell Transplantation. SHILAP Revista de lepidopterología. 3(6). B139–71. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zimu Gong Breakdown of academic impact, for papers by Elisa Carraro Breakdown of academic impact, for papers by PM Parikh Breakdown of academic impact, for papers by Stefano Fiori Breakdown of academic impact, for papers by Tomoko Yanai Breakdown of academic impact, for papers by Rina Kansal Breakdown of academic impact, for papers by Francesca Lunghi Breakdown of academic impact, for papers by Chunju Zhou Breakdown of academic impact, for papers by Elizabeth L. Courville Breakdown of academic impact, for papers by Robert Peter Gale
Rankless by CCL
2026